Friedenthal Financial Eli Lilly & CO Transaction History

Friedenthal Financial

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $582,724 - $779,603	984 Added 1312.0%	1,059 $823,000
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $633,904 - $747,289	-1,207 Reduced 94.15%	75 $43,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $151,710 - $209,155	-349 Reduced 21.4%	1,282 $688,000
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $572,056 - $764,906	1,631 New	1,631 $764,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Friedenthal Financial, based on Form 13F filings with the SEC.

Stay updated on Friedenthal Financial with notifications on news.